Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2003
03/26/2003EP1294375A2 Method of treatment of seborrheic dermatitis
03/26/2003EP1294374A1 Flavone/flavanone derivatives for the systemic treatment and prophylaxis of uv-induced dermatoses
03/26/2003EP1294373A1 Pharmaceutical disinfectants comprising usnic acid and essential oils
03/26/2003EP1294372A2 Dry powder formulation comprising racecadotril
03/26/2003EP1294371A1 Medium chain fatty acids applicable as antimicrobial agents
03/26/2003EP1294370A2 Triterpenoid derivatives
03/26/2003EP1294369A1 NOVEL FORMULATIONS OF $g(a)-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE
03/26/2003EP1294368A1 Management of snoring by oral administration of dimethyl sulfone
03/26/2003EP1294367A2 Oral compositions comprising host-response modulating agent
03/26/2003EP1294366A1 Pharmaceutical compounds for treating copd
03/26/2003EP1294365A2 Cytotoxic agents comprising single-stranded and/or looped dna
03/26/2003EP1294364A1 Stable gabapentin having ph within a controlled range
03/26/2003EP1294362A1 Novel process for preparing crystalline particles
03/26/2003EP1294361A2 Compositions and methods to improve the oral absorption of antimicrobial agents
03/26/2003EP1294360A1 Novel process for preparing and harvesting crystalline particles
03/26/2003EP1294359A1 Process for preparing and harvesting crystalline particles
03/26/2003EP1294358A2 Wet milling process
03/26/2003EP1294357A1 Bioavailable dosage form of isotretinoin
03/26/2003EP1294356A2 Sustained release delivery systems for solutes
03/26/2003EP1294355A1 Use of inulin and inulin derivatives
03/26/2003EP1294354A1 Use of inulins and inulin derivatives
03/26/2003EP1294353A1 Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
03/26/2003EP1294349A2 Use of egf-r protein tyrosine kinase inhibitors for preventing photoaging in human skin
03/26/2003EP1294348A2 Skin preparation
03/26/2003EP1294240A2 Compositions and methods for body weight management
03/26/2003EP1263466A4 Methods and compositions for dietary supplements
03/26/2003EP1225810B1 Method for treatment of chronic venous insufficiencies using an extract of red vine leaves
03/26/2003EP1212315B1 Novel chalcones
03/26/2003EP1212311B1 Chalcone coumarins
03/26/2003EP1200431B1 Quinuclidine derivatives and their use as muscarinic m3 receptors ligands
03/26/2003EP1198226B1 Mesalazine controlled release oral pharmaceutical compositions
03/26/2003EP1185528A4 Inhibitors of il-12 production
03/26/2003EP1175420B1 Process for preparing n6-substituted deaza-adenosine derivatives
03/26/2003EP1159274B1 Method for the preparation of citalopram
03/26/2003EP1159269B1 Anti-imflammatory indole derivatives
03/26/2003EP1149089B1 PROCESS TO PREPARE TETRAHYDROTHIOPYRAN-o-FLUORINATED CARBAMATES
03/26/2003EP1146873A4 Anti-androgens and methods for treating disease
03/26/2003EP1140960A4 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
03/26/2003EP1140917B1 S-oxide lipid lowering compounds
03/26/2003EP1140195B1 Oil-in-water emulsion exhibiting a protective action against damages to human organs resulting from peroxidation, and the production and use thereof
03/26/2003EP1128725B1 Disposable premoistened wipe containing an antimicrobial protease inhibitor
03/26/2003EP1126848B1 Plastics container containing stabilised drug formulations
03/26/2003EP1124559B1 Compositions for the treatment and prevention of neurological and pathopsychological diseases
03/26/2003EP1119366B1 Animal stereotypy
03/26/2003EP1105384B1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/26/2003EP1098893B1 Cyclic compounds useful in the treatment of dyslipidemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process
03/26/2003EP1098631B1 Pharmaceutical composition in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy
03/26/2003EP1091948B1 Tubulin binding compounds (cobra)
03/26/2003EP1087735B1 Adhesively applied external nasal strips and dilators containing medications and fragrances
03/26/2003EP1083906A4 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
03/26/2003EP1077703B1 Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
03/26/2003EP1075263B1 Aqueous process for manufacturing paroxetine solid dispersions
03/26/2003EP1066292B1 Metallocorrinoids as biologically compatible carriers of pharmacological agents
03/26/2003EP1042339B1 Carbohydrates, useful in solid delivery systems
03/26/2003EP1041969B1 Novel pharmaceutical compositions of uridine triphosphate
03/26/2003EP1032373B1 Drug delivery systems utilizing liquid crystal structures
03/26/2003EP1028717B1 Unsubstituted polydiallylamine for treating hypercholesterolemia
03/26/2003EP1027325B1 Lipophilic diesters of chelating agents
03/26/2003EP1025085B1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
03/26/2003EP1021432B1 Halogen substituted tetracyclic tetrahydrofuran derivatives
03/26/2003EP1011346B1 Animal feed containing carboxylic acids
03/26/2003EP1007029A4 Methods and compositions for treatment of ovarian cancer
03/26/2003EP0998477B1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
03/26/2003EP0998454B1 Metalloproteinase inhibitors
03/26/2003EP0991649B1 Angiogenesis inhibiting thiadiazolyl pyridazine derivatives
03/26/2003EP0977748B1 Substituted benzopyran derivatives for the treatment of inflammation
03/26/2003EP0977735B1 Vitronectin receptor antagonists
03/26/2003EP0973756B1 Thiodepsipeptides for combating endoparasites and a method for producing the same
03/26/2003EP0970080B1 Imino-aza-anthracyclinone derivatives for the treatment of amyloidosis
03/26/2003EP0969822B1 Determination of the propensity of an organ or tissue for cancer by determining of its imprinting pattern
03/26/2003EP0932409B1 A method for producing an extract from valeriana officinalis containing high levels of valerenic acid
03/26/2003EP0930310B1 Isocoumarin derivatives and use thereof in drugs
03/26/2003EP0882041B1 Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents
03/26/2003EP0871653B1 Novel amino acid derivatives, methods of producing them, and pharmaceutical compounds containing these compounds
03/26/2003EP0863757B1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
03/26/2003EP0847240B1 Novel embolizing compositions
03/26/2003EP0841931B1 Pharmaceutical composition
03/26/2003EP0841926B1 Endothelin receptor antagonists
03/26/2003EP0833819B1 Novel n-(2-oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
03/26/2003EP0833658B1 Inhibin compositions and methods of enhancing production performance
03/26/2003EP0820225B1 Fast acting and persistent topical antiseptic
03/26/2003EP0806941B1 Low rigidity liposomal antibacterial composition
03/26/2003EP0804418B1 Platelet aggregation inhibitors
03/26/2003EP0804229B1 Use of amlodipine, a salt thereof or felodipin in combination with an ace inhibitor in the manufacture of a medicament for the treatment of nonischemic congestive heart failure
03/26/2003EP0801640B1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
03/26/2003EP0801563B1 The use of 2,3-alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
03/26/2003EP0797453B1 Composition for treatment of malignant tumors and their metastases
03/26/2003EP0793656B1 Novel benzyl pyrimidines
03/26/2003EP0763026B1 Gastrin and cck antagonists
03/26/2003EP0606248B1 Heteroaryl amines as novel acetyl cholinesterase inhibitors
03/26/2003CN1406283A Method of purifying a fermentation broth
03/26/2003CN1406238A A novel crystalline form of N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl] benzoyl]-L-glutamic acid and process therefor
03/26/2003CN1406237A Novel benzosultam oxazolidinone antibacterial agents
03/26/2003CN1406234A 8,8A-dihydro-indeno [1,2-D] thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament
03/26/2003CN1406233A Medicine for viral diseases
03/26/2003CN1406231A Pyrimidine compounds
03/26/2003CN1406230A 2,4-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
03/26/2003CN1406229A Pyrimidine compounds
03/26/2003CN1406228A 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
03/26/2003CN1406227A Aryl fused azapolycy clic compounds
1 ... 5524 5525 5526 5527 5528 5529 5530 5531 5532 5533 5534 5535 5536 5537 5538 5539 5540 5541 5542 5543 5544 ... 7860